These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2857614

  • 1. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans.
    Waterfall JF, Rhodes KF, Lattimer N.
    Clin Sci (Lond); 1985; 68 Suppl 10():21s-24s. PubMed ID: 2857614
    [Abstract] [Full Text] [Related]

  • 2. The effects of some alpha-adrenoceptor antagonists on the responses of the canine saphenous vein to B-HT 933, UK-14304 and methoxamine.
    Rhodes KF, Waterfall JF.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):261-8. PubMed ID: 2884574
    [Abstract] [Full Text] [Related]

  • 3. Subtype determination of presynaptic alpha 2-autoreceptors in the rabbit pulmonary artery and human saphenous vein.
    Molderings GJ, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):483-90. PubMed ID: 8751076
    [Abstract] [Full Text] [Related]

  • 4. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC, Roach AG, Strachan DA, Virdee NK.
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [Abstract] [Full Text] [Related]

  • 5. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.
    Lattimer N, McAdams RP, Rhodes KF, Sharma S, Turner SJ, Waterfall JF.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):312-8. PubMed ID: 6151116
    [Abstract] [Full Text] [Related]

  • 6. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
    Bill SJ, Boniface A, Haroun F, McAdams RP, Lattimer N, Rhodes KF.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):418-22. PubMed ID: 2881217
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Doxey JC, Lane AC, Roach AG, Virdee NK.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
    [Abstract] [Full Text] [Related]

  • 8. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I, Coates J, Drew GM, Sullivan AT.
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [Abstract] [Full Text] [Related]

  • 9. Alpha2-adrenoceptor ligands inhibit alpha1-adrenoceptor-mediated contraction of isolated rat arteries.
    Artigues-Varin C, Richard V, Varin R, Mulder P, Thuillez C.
    Fundam Clin Pharmacol; 2002 Aug; 16(4):281-7. PubMed ID: 12570016
    [Abstract] [Full Text] [Related]

  • 10. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG, Vizi ES.
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [Abstract] [Full Text] [Related]

  • 11. A difference in the affinity of some selective alpha 2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit.
    Lattimer N, Rhodes KF.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):278-81. PubMed ID: 2862589
    [Abstract] [Full Text] [Related]

  • 12. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC, Roach AG, Smith CF.
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [Abstract] [Full Text] [Related]

  • 13. Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein.
    Alabaster VA, Keir RF, Peters CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):33-6. PubMed ID: 2864638
    [Abstract] [Full Text] [Related]

  • 14. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.
    Alabaster VA, Keir RF, Peters CJ.
    Br J Pharmacol; 1986 Jul; 88(3):607-14. PubMed ID: 2874857
    [Abstract] [Full Text] [Related]

  • 15. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
    Hicks PE, Langer SZ, Macrae AD.
    Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
    [Abstract] [Full Text] [Related]

  • 16. L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist.
    Pettibone DJ, Clineschmidt BV, Lotti VJ, Martin GE, Huff JR, Randall WC, Vacca J, Baldwin JJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):110-6. PubMed ID: 2875395
    [Abstract] [Full Text] [Related]

  • 17. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA, Hieble JP, Ruffolo RR.
    Pharmacology; 1991 Jun; 43(1):1-13. PubMed ID: 1683709
    [Abstract] [Full Text] [Related]

  • 18. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
    Perrone MH, Hamel LT, Ferrari RA, Haubrich DR.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D, Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.